Central Nervous System Agents in Medicinal Chemistry
Title: Editorial
Volume: 11 Issue: 1
Author(s): Maria L Lopez-Rodriguez
Affiliation:
Export Options
About this article
Cite this article as:
L Lopez-Rodriguez Maria, Editorial, Central Nervous System Agents in Medicinal Chemistry 2011; 11 (1) . https://dx.doi.org/10.2174/187152411794961059
DOI https://dx.doi.org/10.2174/187152411794961059 |
Print ISSN 1871-5249 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6166 |
14
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Neuroanatomical and Neurophysiological Abnormalities in the Neural Correlates of Face Processing in Schizophrenia
Current Psychiatry Reviews The Genetic Architecture of Rheumatoid Arthritis: From Susceptibility to Clinical Subphenotype Associations
Current Topics in Medicinal Chemistry Exploring the Relationship of Functional Network Connectivity to Latent Trajectories of Alcohol Use and Risky Sex
Current HIV Research Protein-Protein and Peptide-Protein Interactions of NudE-Like 1 (Ndel1): A Protein Involved in Schizophrenia
Current Protein & Peptide Science Mutations in PRKN and SNCA Genes Important for the Progress of Parkinson’s Disease
Current Genomics Multiple Defects in Energy Metabolism in Alzheimers Disease
Current Drug Targets 3,4-Dihydroxyphenylacetaldehyde: A Potential Target for Neuroprotective Therapy in Parkinsons Disease
Current Drug Targets - CNS & Neurological Disorders The Discovery and Potential of N-Sulfonylated Dipeptide VLA-4 Antagonists
Current Topics in Medicinal Chemistry Collaboration of the Joint Research Centre and European Customs Laboratories for the Identification of New Psychoactive Substances
Current Pharmaceutical Biotechnology Editorial [Hot topic: Ocular Immunology (Guest Editor: Gerhild Wildner)]
Current Immunology Reviews (Discontinued) In-Silico Identification of Drug Lead Molecule Against Pesticide Exposed-neurodevelopmental Disorders Through Network-Based Computational Model Approach
Current Bioinformatics Crisis Intervention Related to the Use of Psychoactive Substances in Recreational Settings - Evaluating the Kosmicare Project at Boom Festival
Current Drug Abuse Reviews The Brain-Immune-Gut Triangle: Innate Immunity in Psychiatric and Neurological Disorders
Current Immunology Reviews (Discontinued) New Approaches to Antidepressant Drug Design: Cytokine-Regulated Pathways
Current Pharmaceutical Design Hypertension and Compliance to Treatment in the Primary Care Setting: Key Issues from the Literature Review
Current Hypertension Reviews Default Mode Network Connectivity and Related White Matter Disruption in Type 2 Diabetes Mellitus Patients Concurrent with Amnestic Mild Cognitive Impairment
Current Alzheimer Research The Genetic Variation of ARRB2 is Associated with Late-onset Alzheimer's Disease in Han Chinese
Current Alzheimer Research Is Dopamine Neurotransmission Altered in Prodromal Schizophrenia? A Review of the Evidence
Current Pharmaceutical Design Cerebrovascular Ultrasonography for Selecting Patients for Stroke Intervention
Recent Patents on CNS Drug Discovery (Discontinued) The Epidemiology and Health Effects of Tobacco Smoke Exposure
Current Pediatric Reviews